Dr. Thomas L. Schwartz, MD

Dr. Schwartz practices at Psychiatry Faculty Practice, Inc. in Syracuse, New York.

Dr. Schwartz's NPI, 1447286406, was assigned on June 23, 2006. Dr. Schwartz holds New York license 204258.

Dr. Schwartz's primary practice is Psychiatry Faculty Practice, Inc., at 713 Harrison St, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 464-3119.

Dr. Schwartz's primary practice is Psychiatry Faculty Practice, Inc. in Syracuse, New York. Dr. Schwartz is also affiliated with Upstate University Hospital. The medical group on file is Psychiatry Faculty Practice. Dmand AI also links Dr. Schwartz to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schwartz practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Schwartz's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Schwartz is licensed in New York.

CMS data shows 30 Medicare services from Dr. Schwartz across 1 procedure code in 2022, for 23 Medicare patients. Medicare paid $778 for them. Every service was in an office.

CMS counts 23 Medicare patients who saw Dr. Schwartz in 2024. 75% of them have anxiety, and 75% have depression. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schwartz's median patient age at 51, with 66% women.

In 2024, Dr. Schwartz wrote 138 Medicare Part D claims for 12 patients. 75% of them were for generic drugs. CMS names the drug for 81 of them, across 5 drugs with 11 or more claims each, at $94,059 in total drug cost. In 2023, CMS named 139 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Schwartz for performance year 2024, reported as part of a group. Dr. Schwartz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schwartz as offering telehealth.

Dmand AI links 23 papers to Dr. Schwartz, published from 2011 to 2025. 2015 was the busiest year, with 3. The most frequent topics are Bipolar Disorder, Antipsychotic Agents and Anxiety Disorders. Dr. Schwartz has published most often in Drugs Context. Dr. Schwartz's most frequent co-authors are Thomas Lee Schwartz, MD, Charles R. Conway, MD and Soojae Lee Hollowell.

Dmand AI links Dr. Schwartz to 2 clinical trials. Conditions studied include Depressive Disorder, Treatment-Resistant, Fibromyalgia and Depressive Disorder.

CMS Open Payments shows 7 general payments to Dr. Schwartz from 5 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 98% of the total. Janssen Pharmaceuticals, Inc paid the most, $4,088.